Total planned funding: $513,370,528
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Namibia | $513,370,528 |
Organizational Types
NGO | $131,156,151 |
Private Contractor | $101,958,744 |
Own Agency | $73,465,000 |
Host Country Government Agency | $72,846,004 |
Unknown | $57,047,466 |
University | $45,773,036 |
Parastatal | $10,130,096 |
Implementing Agency | $8,582,829 |
Other USG Agency | $4,800,721 |
FBO | $3,836,723 |
Multi-lateral Agency | $3,773,758 |
Program Areas
Treatment | $136,545,178 |
Prevention | $107,813,358 |
Care | $105,165,653 |
Governance and Systems | $71,019,434 |
Management and Operations | $53,673,187 |
Testing | $39,153,718 |
Budget Codes
HTXS: Treatment: Adult Treatment | $108,940,455 |
HVMS: Management and Operations | $53,673,187 |
HKID: Care: Orphans and Vulnerable Children | $39,644,205 |
HVCT: Testing: HIV Testing and Counseling | $39,153,718 |
HBHC: Care: Adult Care and Support | $36,320,822 |
OHSS: Health Systems Strengthening | $35,143,837 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $33,880,199 |
HVOP: Sexual Prevention: Other Sexual Prevention | $27,110,962 |
HVSI: Strategic Information | $26,697,043 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $21,815,310 |
HVTB: Care: TB/HIV | $17,591,530 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $16,520,533 |
HTXD: Treatment: ARV Drugs | $14,817,037 |
PDTX: Treatment: Pediatric Treatment | $12,787,686 |
PDCS: Care: Pediatric Care and Support | $11,609,096 |
HLAB: Laboratory Infrastructure | $9,178,554 |
HMBL: Biomedical Prevention: Blood Safety | $5,428,898 |
HMIN: Biomedical Prevention: Injection Safety | $3,057,456 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Potentia Namibia:
$60,116,859
Countries/Regions
Not Available:
$49,413,739
Countries/Regions
USG Aggregated Agencies:
$48,876,148
Countries/Regions